文章

1640971-60-3,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-related-compound-11.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:16:122024-07-07 00:16:12Tofacitinib Impurity 10 CAS号 1640971-60-3
1092578-45-4,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-related-compound-13.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:16:122024-07-07 00:16:12Tofacitinib Impurity 12 CAS号 1092578-45-4
479633-63-1,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-r.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity R CAS号 479633-63-1
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-related-compound-15.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity 13 CAS号 N/A
2056104-91-5,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-21.jpg
624
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity 15 CAS号 2056104-91-5
2459302-82-8,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-25.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity 19 CAS号 2459302-82-8
2174011-55-1,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-c-citrate.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:12:582024-07-07 00:12:58Tofacitinib Impurity C Citrate CAS号 2174011-55-1
1821769-41-8,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-i.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:12:582024-07-07 00:12:58Tofacitinib Impurity I CAS号 1821769-41-8
2328165-36-0,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-acid-impurity.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:12:582024-07-07 00:12:58Tofacitinib Acid Impurity CAS号 2328165-36-0
1252883-90-1,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-p.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:12:582024-07-07 00:12:58Tofacitinib Impurity P CAS号 1252883-90-1
Scroll to top